Literature DB >> 9119739

Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate.

Y Nishiyama1, T Tanaka, H Naitoh, C Mori, M Fukumoto, H Hiai, S Toyokuni.   

Abstract

An iron chelate, ferric nitrilotriacetate (Fe-NTA), induces renal proximal tubular necrosis, a consequence of free radical-associated damage, that ultimately leads to a polycystic change of the renal cortex and a high incidence of renal cell carcinoma (RCC) in rodents. The differential display technique was used to search for inducible genes in the kidney of male Wistar rats treated with Fe-NTA and in the induced RCCs. Six fragments were selected that showed specific quantitative changes in mRNA. Two of them exhibited similar patterns in northern blots as well. One fragment showed a high homology (89%) to murine integrin-associated protein (IAP; CD47). We thus cloned rat IAP cDNA including the entire coding region for use in further analysis. Rat IAP cDNA showed a 21-amino-acid deletion that was also observed in human, but not in mouse. Northern blots revealed that IAP was consistently overexpressed in non-tumorous parts of the kidney (2.4-fold increase, n = 9, P < 0.0001) as compared with matched controls 1 to 2 years after Fe-NTA treatment. IAP overexpression of more than 2.9-fold was found in 25% (2/8) of RCCs studied, and was limited to cases of a high histological grade and lung metastasis. Unexpectedly, IAP expression was higher in the non-tumorous part of the kidney after Fe-NTA treatment (2.8-fold) than in RCC (1.5-fold) in each case (n = 4, P < 0.05). Abundant expression of IAP mRNA in the renal tubular epithelium after Fe-NTA treatment and RCC cells was observed by in situ hybridization. The results suggest that IAP overexpression may be associated with Fe-NTA-induced renal cortical tubular damage and regeneration that lead to a polycystic state, and with tumor progression and metastasis of the induced RCCs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119739      PMCID: PMC5921365          DOI: 10.1111/j.1349-7006.1997.tb00356.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  25 in total

1.  A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells.

Authors:  M A Schwartz; E J Brown; B Fazeli
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

2.  Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis.

Authors:  M S Dunnill; P R Millard; D Oliver
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

3.  Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice.

Authors:  S Toyokuni; S Okada; S Hamazaki; Y Minamiyama; Y Yamada; P Liang; Y Fukunaga; O Midorikawa
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

Review 4.  A review of the environmental and mammalian toxicology of nitrilotriacetic acid.

Authors:  R L Anderson; W E Bishop; R L Campbell
Journal:  Crit Rev Toxicol       Date:  1985       Impact factor: 5.635

5.  Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis.

Authors:  M Awai; M Narasaki; Y Yamanoi; S Seno
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

6.  Elongation factor 1 delta is enhanced following exposure to ionizing radiation.

Authors:  M Jung; A D Kondratyev; A Dritschilo
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

7.  Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate.

Authors:  S Toyokuni; K Uchida; K Okamoto; Y Hattori-Nakakuki; H Hiai; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

8.  DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate.

Authors:  S Toyokuni; T Mori; M Dizdaroglu
Journal:  Int J Cancer       Date:  1994-04-01       Impact factor: 7.396

9.  Isolation of differentially expressed sequence tags from human breast cancer.

Authors:  M A Watson; T P Fleming
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry.

Authors:  X C Xu; J L Clifford; W K Hong; R Lotan
Journal:  Diagn Mol Pathol       Date:  1994-06
View more
  10 in total

Review 1.  The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Pediatr Nephrol       Date:  2018-11-03       Impact factor: 3.714

Review 2.  Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.

Authors:  Natasha M Rogers; Mingyi Yao; Enrico M Novelli; Angus W Thomson; David D Roberts; Jeffrey S Isenberg
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

Review 3.  Osteoclasts and giant cells: macrophage-macrophage fusion mechanism.

Authors:  A Vignery
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

4.  Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma.

Authors:  Lei Wu; Guang-Tao Yu; Wei-Wei Deng; Liang Mao; Lei-Lei Yang; Si-Rui Ma; Lin-Lin Bu; Ashok B Kulkarni; Wen-Feng Zhang; Lu Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

5.  Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation.

Authors:  David R Soto-Pantoja; Jeff S Isenberg; David D Roberts
Journal:  J Genet Syndr Gene Ther       Date:  2011-09-26

Review 6.  CD47 signaling pathways controlling cellular differentiation and responses to stress.

Authors:  David R Soto-Pantoja; Sukhbir Kaur; David D Roberts
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-02-24       Impact factor: 8.250

7.  Brain CD47 expression in a swine model of intracerebral hemorrhage.

Authors:  Xiang Zhou; Qing Xie; Guohua Xi; Richard F Keep; Ya Hua
Journal:  Brain Res       Date:  2014-06-12       Impact factor: 3.252

Review 8.  Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47.

Authors:  David R Soto-Pantoja; Erica V Stein; Natasha M Rogers; Maryam Sharifi-Sanjani; Jeffrey S Isenberg; David D Roberts
Journal:  Expert Opin Ther Targets       Date:  2012-10-27       Impact factor: 6.902

9.  Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.

Authors:  Thomas W Miller; Joshua D Amason; Elsa D Garcin; Laurence Lamy; Patricia K Dranchak; Ryan Macarthur; John Braisted; Jeffrey S Rubin; Teresa L Burgess; Catherine L Farrell; David D Roberts; James Inglese
Journal:  PLoS One       Date:  2019-07-05       Impact factor: 3.240

10.  Key pathways and genes controlling the development and progression of clear cell renal cell carcinoma (ccRCC) based on gene set enrichment analysis.

Authors:  Haipeng Huang; Yanyan Tang; Wenwu He; Qi Huang; Jianing Zhong; Zhanbin Yang
Journal:  Int Urol Nephrol       Date:  2013-08-14       Impact factor: 2.370

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.